Proteomics Software and CRO Solutions for Discovery and Validation

"I have been working with BSI team for more than a year now. Since they are able to handle latest ZT DIA scan formats from Zeno TOF instrument, we were introduced to them by SCIEX. As a result of that introduction, we have expanded to many other projects. The BSI team closely collaborates with us on glycosylation analysis for projects such as bipolar disorder and organ on chip samples. Analysis of narrow isolated MS2 data from Astral orbitrap for analysis of limited samples is another large area of collaboration. PEAKS provides unique knowledge and precision of results from our data analysis compared to other search engines we were using in our laboratory. I am looking forward to our continuing successful collaboration on even more challenging synthetic biology projects."

Bogdan Budnik, Ph.D.
Director of Biomarkers and Drug Target Discovery

"We've relied on PEAKS as the foundation of our neuropeptidomics workflow since 2007. When we first adopted the software, reliable de novo peptide sequencing remained a significant challenge, particularly for endogenous peptides, where the lack of enzyme specificity and the presence of numerous post-translational modifications complicated peptide identification. PEAKS’ powerful de novo sequencing capabilities enabled us to confidently characterize endogenous peptides, including novel peptides that would have been difficult or impossible to identify using conventional database searches alone. That early advantage, combined with outstanding customer support, has kept us with Bioinformatics Solutions for nearly two decades. As our instrumentation evolved, PEAKS’ compatibility with raw data from multiple mass spectrometry vendors eliminated the need to switch analysis platforms. At the same time, continual software enhancements that kept pace with advances in mass spectrometry allowed us to adopt new technologies seamlessly. Together with its intuitive data analysis tools, these capabilities have significantly accelerated our peptide discovery efforts and supported numerous peer-reviewed publications. PEAKS has been a reliable and forward-looking partner in our research, enabling us to tackle increasingly complex neuropeptidomics challenges with confidence."

Elena Romanova, Ph.D.
Research Assistant Professor

"PEAKS is an intuitive and powerful software platform for proteomics data analysis that has been especially valuable in our core facility. Its user-friendly interface allows both experienced and new users to quickly become proficient, making it well suited for supporting researchers with diverse levels of expertise and a wide range of proteomics projects. One of PEAKS' greatest strengths is its continuous development. The software is always improving, with new features and enhancements driven by the evolving needs of the proteomics community. The development team actively listens to customer feedback and incorporates user suggestions into future releases, demonstrating a strong commitment to meeting users' needs. Equally impressive is the customer support. The PEAKS support team consistently provides prompt, knowledgeable responses and valuable feedback, helping us efficiently resolve issues. For a core facility that supports multiple users and projects, the combination of an intuitive interface, continuous innovation, and responsive technical support makes PEAKS a highly reliable and valuable solution."

Chaochao Chen, Ph.D.
Research Scientist